1[1]Miake J,Marba'n E,Nuss HB.Gene therapy:biological pacemaker created by gene transfer[J].Nature,2002,419(6903):132-133.
2[2]Xue T,Cho HC,Akar FG,et al.Functional intergration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with qniescent recipient ventricular cardiomyocytes[J].Circulation,2005,111 (1):11-20.
3[3]Tse HF,Xue T,Lau CP,et al.Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model[J].Circulation,2006,114(10):1000-1011.
4[4]Edelberg JM,Aird WC,Rosenberg RD.Enhancement of murine cardiac chronotropy by the molecular transfer of the human β2-adrenergic receptor cDNA[J].J Clin Invest,1998,101 (2):337-343.
5[5]Qu J,Plotnikov AN,Danilo JR,et al.Expression and function of a biological pacemaker in canine heart[J].Circulation,2003,107(8):1106-1109.
6[6]Plotnikov AN,Sosunov EA,Qu J,et al.A biological pacemaker implanted in the canine left bundle branch provides ventricular escape rhythms having physiologically acceptable rates[J].Circulation,2004,109(4):506-512.
7[7]Azene EM,Xue T,Marban E,et al.Non-equilibrium behavior of HCN channels:insights into the role of HCN channels in native and engineered pacemakers[J].Cardiovasc Res,2005,67(2):263-273.
8[8]Lesso H,Li RA.Helical secondary structure of the external S3-S4 linker of pacemaker (HCN)channels revealed by sitedependent perturbations of activation phenotype[J].J Biol Chem,2003,278 (25):22290-22297.
9[9]Tsang S,Lesso H,Li RA.Dissecting the structural and fun-ctional roles of the S3-S4 linker of pacemaker (HCN)channels by systematic length alterations[J].J Biol Chem,2004,279(42):43752-43759.
